Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

NCT00333736 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

337

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus

Interventions

DEVICE: Biojector

Sponsor

Canadian Immunodeficiency Research Collaborative

Collaborators

[object Object]